Bristol-Myers Gets FDA Acceptance of Review for Subcutaneous Opdivo Formulation

By Colin Kellaher


Bristol Myers Squibb on Monday said the Food and Drug Administration has accepted its application seeking approval of an subcutaneous formulation of its blockbuster cancer...

Related Keywords

San Diego ,California ,United States ,Halozyme Enhanze ,Bristol Myers ,Bristol Myers Squibb ,Colin Kellaher ,Drug Administration ,Myers Squibb ,Dow Jones ,Markets ,